BIOMAT Database Logo BIOMAT Database Logo

Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus. 2007

Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
AlphaVax Inc., Research Triangle Park, NC 27709, USA.

We used a replication-incompetent, single-cycle, alphavirus replicon vector system to produce virus-like replicon particles (VRP) expressing the extracellular domain of human cytomegalovirus (CMV) glycoprotein B or a pp65/IE1 fusion protein. Efficient production methods were scaled to produce pilot lots and clinical lots of each alphavirus replicon vaccine component. The vaccine induced high-titered antibody responses in mice and rabbits, as measured by ELISA and CMV neutralization assays, and robust T-cell responses in mice, as measured by IFN-gamma ELISPOT assay. A toxicity study in rabbits showed no adverse effects in any toxicology parameter. These studies support clinical testing of this novel CMV alphavirus replicon vaccine in humans.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D012093 Replicon Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Replication Unit,Replication Units,Replicons,Unit, Replication,Units, Replication
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D005260 Female Females
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle

Related Publications

Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.
November 2007, Vaccine,
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle.
July 2010, The Journal of general virology,
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.
October 2007, Journal of virology,
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
September 2009, Epidemiology and infection,
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
Heterologous prime-boost immunizations with a virosomal and an alphavirus replicon vaccine.
February 2011, Molecular pharmaceutics,
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
October 2014, Journal of virology,
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
Development of a nanoparticle-based oral vaccine for Atlantic salmon against ISAV using an alphavirus replicon as adjuvant.
July 2015, Fish & shellfish immunology,
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
March 2012, Vaccine,
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
Development and Evaluation of DNA Vaccine Against Salmonid Alphavirus.
January 2022, Methods in molecular biology (Clifton, N.J.),
Elizabeth A Reap, and John Morris, and Sergey A Dryga, and Maureen Maughan, and Todd Talarico, and Robert E Esch, and Sarah Negri, and Bruce Burnett, and Andrew Graham, and Robert A Olmsted, and Jeffrey D Chulay
An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
October 2003, Journal of virology,
Copied contents to your clipboard!